Fixed dose combination emtricitabine/tenofovir/efavirenz initiated during Acute HIV Infection; 96-week efficacy and durability

OBJECTIVE: Demonstrate rapid initiation of co-formulated treatment during acute HIV infection (AHI) is feasible and efficacious. DESIGN: Prospective, single-arm open label study of once daily emtricitabine/tenofovir/efavirenz initiated during AHI. METHODS: We provide final data through week 96-week...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:AIDS
Huvudupphovsmän: GAY, Cynthia L., WILLIS, Sarah J., COPE, Anna B., KURUC, JoAnn D., MCGEE, Kara S., SEBASTIAN, Joe, CROOKS, Amanda M., MCKELLAR, Mehri S., MARGOLIS, David M., FISCUS, Susan A., HICKS, Charles B., FERRARI, Guido, ERON, Joseph J.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2016
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5101138/
https://ncbi.nlm.nih.gov/pubmed/27662549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000001255
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk